|
GTF2E1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.270200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.641800E-01 |
| Normal-vs-Stage2 |
2.404200E-01 |
| Normal-vs-Stage3 |
2.721600E-01 |
| Normal-vs-Stage4 |
4.747800E-01 |
| Stage1-vs-Stage2 |
2.226200E-01 |
| Stage1-vs-Stage3 |
2.377600E-01 |
| Stage1-vs-Stage4 |
5.364400E-01 |
| Stage2-vs-Stage3 |
8.652600E-01 |
| Stage2-vs-Stage4 |
6.459000E-01 |
| Stage3-vs-Stage4 |
7.298600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.378400E-01 |
| Normal-vs-AfricanAmerican |
2.443200E-01 |
| Normal-vs-Asian |
6.743600E-02 |
| Caucasian-vs-AfricanAmerican |
4.492600E-01 |
| Caucasian-vs-Asian |
3.012100E-02 |
| AfricanAmerican-vs-Asian |
3.113700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.823800E-01 |
| Normal-vs-Female |
9.155600E-01 |
| Male-vs-Female |
1.151980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.827400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.425800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.718410E-01 |
| Normal-vs-Age(81-100Yrs) |
4.315200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.435400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.895970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.154360E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.969900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.606600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.332500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.343400E-01 |
| Normal-vs-Grade 2 |
7.179000E-01 |
| Normal-vs-Grade 3 |
1.616180E-01 |
| Normal-vs-Grade 4 |
8.190800E-01 |
| Grade 1-vs-Grade 2 |
3.333400E-01 |
| Grade 1-vs-Grade 3 |
1.155170E-01 |
| Grade 1-vs-Grade 4 |
3.017200E-01 |
| Grade 2-vs-Grade 3 |
1.577430E-01 |
| Grade 2-vs-Grade 4 |
9.845200E-01 |
| Grade 3-vs-Grade 4 |
4.417200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.882400E-01 |
| Normal-vs-ccB subtype |
5.993000E-01 |
| ccA subtype-vs-ccB subtype |
4.552600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.894000E-01 |
| Normal-vs-N1 |
4.495400E-01 |
| N0-vs-N1 |
2.036200E-01 |
|
|
